FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmacology, namely to a method of using genistein as a diuretic. A method of using genistein as a diuretic consists in administering genistein enterally in dosage of 1 mg/kg of body weight in the form of an aqueous solution.
EFFECT: invention widens the range of agents with diuretic activity.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF PINOCEMBRIN AS DIURETIC AND CREATININURETIC AGENT | 2023 |
|
RU2822937C1 |
| USE OF PINOSTROBIN AS DIURETIC AND CREATINURETIC AGENT | 2023 |
|
RU2816948C1 |
| USE OF QUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802833C1 |
| USE OF HYPEROZIDE AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802832C1 |
| USE OF DIHYDROQUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802874C1 |
| USE OF OREGANOL A WITH DIURETIC ACTIVITY | 2022 |
|
RU2802873C1 |
| USE OF PATULITRIN AS A DIURETIC | 2022 |
|
RU2807938C1 |
| AGENT WITH DIURETIC ACTIVITY | 2016 |
|
RU2619349C1 |
| AGENTS WITH DIURETIC ACTIVITY | 2016 |
|
RU2619350C1 |
| DIURETIC | 2016 |
|
RU2619346C1 |
